Skip to content

Columbia Ventures Corporation

Creating, Discovering and Enhancing Capital Values

  • Team
  • Philosophy
  • Portfolio
    • Augmented Reality
    • Biomedical
    • Energy
    • Food
    • Hospitality
    • Manufacturing
    • Real Estate Development
    • Robotics
    • Software as a Service
    • Telecommunications
    • Past Investments
  • News
  • Contact
Columbia Ventures Corporation

Category: AbSci

AbSci announces completion of $125 million crossover financing to advance AI-powered synthetic biology drug creation platform

Read now on prnewswire.com • March 23, 2021

Unknown's avatarAuthor Columbia VenturesPosted on March 23, 2021Categories AbSci, BIOMEDICAL

Inslee: State’s investment in Vancouver’s AbSci is money well-spent

Read now on Columbian.com • February 20, 2020

1006554144-AbSci_01

Unknown's avatarAuthor Columbia VenturesPosted on February 20, 2020February 21, 2020Categories AbSci, BIOMEDICAL

AbSci closes $15.4 M in Series D funding to accelerate growth and scale

Read now on OleanTimesHerald.com • January 13, 2020

Unknown's avatarAuthor Columbia VenturesPosted on January 13, 2020Categories AbSci, BIOMEDICAL

Vancouver biotech raises $10M funding round, inks manufacturing deal

Read now on BizJournals.com • January 7, 2020

Screen Shot 2020-01-08 at 10.50.16 AM

Unknown's avatarAuthor Columbia VenturesPosted on January 7, 2020January 8, 2020Categories AbSci, BIOMEDICAL

S.W. Washington biotech continues to grow rapidly

Read now on BizJournals.com • September 16, 2019

Screen Shot 2019-09-18 at 10.44.43 AM

Unknown's avatarAuthor Columbia VenturesPosted on September 16, 2019September 18, 2019Categories AbSci, BIOMEDICAL

Engineering a living organism is fascinating

Read now on MCB.Arizona • July 10, 2019

seanmcclain

Unknown's avatarAuthor Columbia VenturesPosted on July 10, 2019July 11, 2019Categories AbSci, BIOMEDICAL

10 life science innovators under 40 to watch

Read now on BioSpace.com • July 10, 2019

6f9cca46-7b21-4703-9276-d70876cc5c12

Unknown's avatarAuthor Columbia VenturesPosted on July 10, 2019Categories AbSci, BIOMEDICAL

AbSci develops game-changing 12-week cell line optimization workflow and adds two new members to its executive team

Read now on PRNewswire.com • April 5, 2019

Unknown's avatarAuthor Columbia VenturesPosted on April 5, 2019April 11, 2019Categories AbSci, BIOMEDICAL

Sanofi enters agreement to use E.Coli for expression optimization

Read now on Outsourcing-Pharma.com • January 15, 2019

Enterobacterias Gram negativas Proteobacteria, bacteria such as salmonella, escherichia coli, yersinia pestis, klebsiella. 3D illustration.

Unknown's avatarAuthor Columbia VenturesPosted on January 15, 2019January 16, 2019Categories AbSci, BIOMEDICAL

Sanofi turns to high titer E. Coli platform in AbSci deal

Read now on BioProcessIntl@.com • January 14, 2019

e-coli-wikimedia

Unknown's avatarAuthor Columbia VenturesPosted on January 14, 2019January 16, 2019Categories AbSci, BIOMEDICAL

Posts pagination

Previous page Page 1 Page 2 Page 3 Next page
  • Team
  • Philosophy
  • Portfolio
    • Augmented Reality
    • Biomedical
    • Energy
    • Food
    • Hospitality
    • Manufacturing
    • Real Estate Development
    • Robotics
    • Software as a Service
    • Telecommunications
    • Past Investments
  • News
  • Contact
Columbia Ventures Corporation Create a website or blog at WordPress.com
Columbia Ventures Corporation
Create a website or blog at WordPress.com
  • Subscribe Subscribed
    • Columbia Ventures Corporation
    • Already have a WordPress.com account? Log in now.
    • Columbia Ventures Corporation
    • Subscribe Subscribed
    • Sign up
    • Log in
    • Report this content
    • View site in Reader
    • Manage subscriptions
    • Collapse this bar
 

Loading Comments...